United States
In the United States Biosimilars Market is experiencing rapid growth due to the increasing adoption of biosimilars as a more affordable alternative to expensive biologics. The approval of several biosimilars by the FDA has opened up opportunities for market expansion. The rising healthcare costs and the expiration of patents for some of the top-selling biologics are key drivers...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian